Open Orphan plc will be rebranding to hVIVO plc on 26 October 2022, learn more here.

18 Mar 2019
Go Back

hVIVO's Alex Mann making an oral presentation at ISRIV 1st Influenza Vaccine Group Meeting, Siena, Italy, March

Share this:

ISRIV 1st Influenza Vaccine Group Meeting, March 31st - April 2nd, Siena, Italy

Alex Man, hVIVO’s Director Clinical Science R&D Operations, will be making an oral presentation at ISRIV 1st Influenza Vaccine Group Meeting. The event takes place between March 31st and April 2nd in Siena, Italy.

Alex Mann, will be presenting on Sunday, March 31st:

  • ‘Understanding Vaccine Correlates: The Human Influenza Challenge Model’ (Sunday, March 31st, Session B, 17:45).

If you would like to make contact with Alex Mann, Director Clinical Science R&D Operations, and Reid Tripp, Executive Vice President, Business Development and Marketing, from hVIVO before or during the ISIRV event in Siena, please use the Contact Us page on this site.

Other recent posts

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.

Contact hVIVO
chevron-down